Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2016 07:46 ET | Source: Theratechnologies inc.

Theratechnologies fait part d'une décision regrettable du ministère de la santé du Québec

MONTRÉAL, QUÉBEC--(Marketwired - 9 juin 2016) - Theratechnologies inc. (TSX:TH) a le regret d'annoncer que le gouvernement du Québec, province où a été...
June 09, 2016 07:45 ET | Source: Theratechnologies inc.

Theratechnologies Announces Regretful Decision by the Quebec Ministry of Health

MONTREAL, QUEBEC--(Marketwired - June 9, 2016) - Theratechnologies inc. (TSX:TH) regretfully announces that the Government of Quebec, the province where EGRIFTA® was discovered, has...
May 24, 2016 07:00 ET | Source: Theratechnologies inc.

Theratechnologies annonce que 82,5% des patients ont atteint le critère principal de l'étude de phase III de l'ibalizumab

MONTRÉAL, CANADA--(Marketwired - 24 mai 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) annonce avoir été avisée par son partenaire, TaiMed Biologics,...
May 24, 2016 07:00 ET | Source: Theratechnologies inc.

Theratechnologies Announces that 82.5% of Patients Achieved the Primary Endpoint in the Phase III Ibalizumab Trial

MONTREAL, CANADA--(Marketwired - May 24, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) announces that it has been notified by its partner, TaiMed Biologics, Inc., of the...
May 17, 2016 12:33 ET | Source: Theratechnologies inc.

Annonces en marge de l'assemblée annuelle de Theratechnologies

MONTRÉAL, QUÉBEC--(Marketwired - 17 mai 2016) - Theratechnologies inc. (TSX:TH) a tenu aujourd'hui son assemblée annuelle des actionnaires. Celle-ci a été...
May 17, 2016 12:32 ET | Source: Theratechnologies Inc.

Announcements in Conjunction With Theratechnologies Annual Meeting

MONTREAL, QUEBEC--(Marketwired - May 17, 2016) - Theratechnologies Inc. (TSX:TH) today held its annual meeting of shareholders for the 2015 fiscal year. It was chaired by Dawn Svoronos,...
May 16, 2016 08:54 ET | Source: Theratechnologies inc.

Theratechnologies inc. : Mise à jour concernant la demande d'approbation réglementaire de la tésamoreline au Brésil

MONTRÉAL, CANADA--(Marketwired - 16 mai 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd'hui, de concert avec son partenaire commercial Sanofi, la...
May 16, 2016 08:53 ET | Source: Theratechnologies Inc.

Theratechnologies Inc.: Update on Tesamorelin Marketing Authorization Application in Brazil

MONTREAL, CANADA--(Marketwired - May 16, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) announced that its commercial partner, Sanofi, along with Theratechnologies, have...
April 27, 2016 20:00 ET | Source: Theratechnologies inc.

Theratechnologies annonce que le recrutement pour l'étude de phase III relative à l'ibalizumab est terminé

MONTRÉAL, QUÉBEC--(Marketwired - 27 avril 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d'annoncer que son partenaire, TaiMed Biologics, Inc., l'a...
April 27, 2016 20:00 ET | Source: Theratechnologies Inc.

Theratechnologies Announces Completion of Enrollment for Phase III Ibalizumab Trial

MONTREAL, QUEBEC--(Marketwired - April 27, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that it has been notified by its partner, TaiMed Biologics,...